Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer

Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals. Herein, we retrospectively compared the characteristics and outcomes of patients with hematologic malignancies (HMs) or hema...

Full description

Bibliographic Details
Main Authors: Dierdre B. Axell-House, Sebastian Wurster, Ying Jiang, Andreas Kyvernitakis, Russell E. Lewis, Jeffrey J. Tarrand, Issam I. Raad, Dimitrios P. Kontoyiannis
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Fungi
Subjects:
mucormycosis
mortality
antifungal therapy
breakthrough mold infection
hematologic malignancy
Online Access:https://www.mdpi.com/2309-608X/7/3/217

Internet

https://www.mdpi.com/2309-608X/7/3/217

Similar Items